Paxlovid (Drug)

Paxlovid Cuts Covid Death Risk. But Those Who Need It Are Not Taking It.

With Covid deaths rising to about 1,500 per week, researchers question why Paxlovid use has remained low among high-risk patients.

By Christina Jewett

Coronavirus (2019-nCoV) Elder Care Elderly Journal of the American Medical Assn Nursing Homes Paxlovid (Drug) Protective Clothing and Gear Research Tests (Medical) Workplace Hazards and Violations

How Nursing Homes Failed to Protect Residents From Covid

A series of hurdles prevented the facilities from shielding older people, despite the best efforts of staff. Experts are calling for reforms before the next virus arrives.

By Paula Span

Coronavirus (2019-nCoV) Drugs (Pharmaceuticals) Food and Drug Administration Paxlovid (Drug) Pfizer Inc United States

F.D.A. Advisers Endorse Paxlovid’s Benefits as a Covid Treatment

While an agency analysis did find signs of Covid “rebound,” the drug significantly reduces hospitalizations and deaths, researchers said.

By Carl Zimmer and Christina Jewett

Beijing (China) BioNTech SE China Coronavirus (2019-nCoV) Drugs (Pharmaceuticals) Drugstores East Asia Hong Kong Hospitals Ibuprofen (Drug) Jinan (China) Pain-Relieving Drugs Paxlovid (Drug) Pfizer Inc Shanghai (China) Shortages

China’s Abrupt Covid Pivot Leaves Many Without Medicines

Millions are desperate to get their hands on fever-reducing drugs and antivirals such as Pfizer’s Paxlovid as infections across China outpace supplies.

By David Pierson Isabelle Qian Olivia Wang and Tiffany May

mosaec